Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gammaitoni

Showing results (121-130 of 230) with videos related to

Pageof 23
Sort By:
Molecular Cancer Therapeutics|March 29, 2012
Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomasGiuliana Cavalloni, Caterina Peraldo-Neia, Ivana Sarotto, et al.
Epilepsy & Behavior : E&B|July 23, 2017
Life impact of caregiving for severe childhood epilepsy: Results of expert panels and caregiver focus groupsMark P Jensen, Kendra S Liljenquist, Fraser Bocell, et al.
Epilepsy & Behavior : E&B|August 27, 2020
Psychosocial impact on siblings of patients with developmental and epileptic encephalopathiesLaurie D Bailey, Lauren Schwartz, Tracy Dixon-Salazar, et al.
Current Medical Research and Opinion|July 14, 2017
Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient populationAn-Sofie Schoonjans, Fabienne Marchau, Bernard P Paelinck, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 6, 2020
Development and validation of the University of Washington caregiver stress and benefit scales for caregivers of children with or without serious health conditionsDagmar Amtmann, Kendra S Liljenquist, Alyssa Bamer, et al.
Epilepsy & Behavior : E&B|April 22, 2017
The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future researchMark P Jensen, Andreas Brunklaus, Liam Dorris, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|June 11, 1999
Establishing community pharmacy-based anticoagulation education and monitoring programsC H Knowlton, O V Thomas, A Williamson, et al.
Anti-Cancer Drugs|July 3, 2008
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumabGiuliana Cavalloni, Ivana Sarotto, Ymera Pignochino, et al.
Pain Medicine (Malden, Mass.)|July 5, 2012
Predicting response to pregabalin from pretreatment pain quality: clinical applications of the pain quality assessment scaleArnold R Gammaitoni, Steven S Smugar, Mark P Jensen, et al.
Expert Opinion on Biological Therapy|July 25, 2015
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectivesMartina Sanlorenzo, Igor Vujic, Adrian Moy, et al.
Pageof 23

Showing results (121-130 of 230) with videos related to

Sort By:
Pageof 23
Molecular Cancer Therapeutics|March 29, 2012
Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomasGiuliana Cavalloni, Caterina Peraldo-Neia, Ivana Sarotto, et al.
Epilepsy & Behavior : E&B|July 23, 2017
Life impact of caregiving for severe childhood epilepsy: Results of expert panels and caregiver focus groupsMark P Jensen, Kendra S Liljenquist, Fraser Bocell, et al.
Epilepsy & Behavior : E&B|August 27, 2020
Psychosocial impact on siblings of patients with developmental and epileptic encephalopathiesLaurie D Bailey, Lauren Schwartz, Tracy Dixon-Salazar, et al.
Current Medical Research and Opinion|July 14, 2017
Cardiovascular safety of low-dose fenfluramine in Dravet syndrome: a review of its benefit-risk profile in a new patient populationAn-Sofie Schoonjans, Fabienne Marchau, Bernard P Paelinck, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|January 6, 2020
Development and validation of the University of Washington caregiver stress and benefit scales for caregivers of children with or without serious health conditionsDagmar Amtmann, Kendra S Liljenquist, Alyssa Bamer, et al.
Epilepsy & Behavior : E&B|April 22, 2017
The humanistic and economic burden of Dravet syndrome on caregivers and families: Implications for future researchMark P Jensen, Andreas Brunklaus, Liam Dorris, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|June 11, 1999
Establishing community pharmacy-based anticoagulation education and monitoring programsC H Knowlton, O V Thomas, A Williamson, et al.
Anti-Cancer Drugs|July 3, 2008
Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumabGiuliana Cavalloni, Ivana Sarotto, Ymera Pignochino, et al.
Pain Medicine (Malden, Mass.)|July 5, 2012
Predicting response to pregabalin from pretreatment pain quality: clinical applications of the pain quality assessment scaleArnold R Gammaitoni, Steven S Smugar, Mark P Jensen, et al.
Expert Opinion on Biological Therapy|July 25, 2015
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectivesMartina Sanlorenzo, Igor Vujic, Adrian Moy, et al.
Pageof 23